Active	Status	Sponsor type	Region	Phase	Filter
8 Active 1 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hall, Megan N
NCT06169176: RAPA-501 Therapy for ALS Expanded Access Protocol	Available	2/3	40	US	RAPA-501 Autologous T cells	Rapa Therapeutics LLC, Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke (NINDS)	Amyotrophic Lateral Sclerosis
FaM, NCT05346315: Food as Medicine Study	Active, not recruiting	N/A	80	US	RDN Medical Nutrition Therapy	Academy of Nutrition and Dietetics	Nutrition Disorders	06/23	11/23
TLIF, NCT04073563: Transforaminal Lumbar Interbody Fusion	Recruiting	N/A	1017	US, RoW	Infuse™ Bone Graft (Infuse™), Intervertebral body fusion device and Medtronic posterior Fixation Systems	Medtronic Spinal and Biologics	Degenerative Disease of the Lumbosacral Spine	04/26	04/28
Johnson, Stephen
NCT06169176: RAPA-501 Therapy for ALS Expanded Access Protocol	Available	2/3	40	US	RAPA-501 Autologous T cells	Rapa Therapeutics LLC, Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke (NINDS)	Amyotrophic Lateral Sclerosis
NCT04998305: TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps	Active, not recruiting	1/2	11	US	TJ-68, Shakuyakukanzoto, Placebo, Placebo Tablet	Hiroshi Mitsumoto, Tsumura & Co., Tokyo, Japan	Amyotrophic Lateral Sclerosis, Muscle Cramp	04/25	04/25
Bojko, Alissa
NCT06169176: RAPA-501 Therapy for ALS Expanded Access Protocol	Available	2/3	40	US	RAPA-501 Autologous T cells	Rapa Therapeutics LLC, Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke (NINDS)	Amyotrophic Lateral Sclerosis
HEALEY ALS, NCT04297683: Platform Trial - Master Protocol	Active, not recruiting	2/3	1500	US	ABBV-CLS-7262, DNL343	Merit E. Cudkowicz, MD, Massachusetts General Hospital	Amyotrophic Lateral Sclerosis	07/25	04/26
NCT04998305: TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps	Active, not recruiting	1/2	11	US	TJ-68, Shakuyakukanzoto, Placebo, Placebo Tablet	Hiroshi Mitsumoto, Tsumura & Co., Tokyo, Japan	Amyotrophic Lateral Sclerosis, Muscle Cramp	04/25	04/25